Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kirk

Showing results (801-810 of 1,074) with videos related to

Pageof 108
Sort By:
Environmental Health Perspectives|December 6, 2008
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West AfricaMark H Kuniholm, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2009
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfectionGregory D Kirk, Jacquie Astemborski, Shruti H Mehta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2011
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplantD C Neujahr, S D Perez, A Mohammed, et al.
Kidney International|October 2, 2004
Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathySteven Hoffmann, Jenny Park, Lynn M Jacobson, et al.
Journal of Viral Hepatitis|October 15, 2025
Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling StudyKyra H Grantz, Derek A T Cummings, Luis Mier-Y-Teran Romero, et al.
Drug and Alcohol Dependence Reports|August 28, 2023
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, MarylandEshan U Patel, Shruti H Mehta, Becky L Genberg, et al.
Journal of Viral Hepatitis|June 29, 2023
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MDCatelyn R Coyle, Michael R Desjardins, Frank C Curriero, et al.
Drug and Alcohol Dependence|April 8, 2022
Epigenome-wide association analyses of active injection drug useChang Shu, Andrew E Jaffe, Sarven Sabunciyan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2015
Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman PrimatesA M Freitas, K P Samy, A B Farris, et al.
The Journal of Infectious Diseases|May 14, 2025
Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugsKyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, et al.
Pageof 108

Showing results (801-810 of 1,074) with videos related to

Sort By:
Pageof 108
Environmental Health Perspectives|December 6, 2008
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West AfricaMark H Kuniholm, Olufunmilayo A Lesi, Maimuna Mendy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2009
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfectionGregory D Kirk, Jacquie Astemborski, Shruti H Mehta, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 14, 2011
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplantD C Neujahr, S D Perez, A Mohammed, et al.
Kidney International|October 2, 2004
Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathySteven Hoffmann, Jenny Park, Lynn M Jacobson, et al.
Journal of Viral Hepatitis|October 15, 2025
Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling StudyKyra H Grantz, Derek A T Cummings, Luis Mier-Y-Teran Romero, et al.
Drug and Alcohol Dependence Reports|August 28, 2023
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, MarylandEshan U Patel, Shruti H Mehta, Becky L Genberg, et al.
Journal of Viral Hepatitis|June 29, 2023
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MDCatelyn R Coyle, Michael R Desjardins, Frank C Curriero, et al.
Drug and Alcohol Dependence|April 8, 2022
Epigenome-wide association analyses of active injection drug useChang Shu, Andrew E Jaffe, Sarven Sabunciyan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 4, 2015
Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman PrimatesA M Freitas, K P Samy, A B Farris, et al.
The Journal of Infectious Diseases|May 14, 2025
Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugsKyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, et al.
Pageof 108